Development and validation of a severity scoring system for Zellweger spectrum disorders

Area of Science:

• Biochemistry
• Genetics
• Medical Research

Background:

• Zellweger spectrum disorders (ZSD) lack a validated severity scoring system, hindering patient care and research.
• Accurate phenotyping is crucial for understanding disease progression and developing targeted therapies.

Purpose of the Study:

• To develop and validate a comprehensive severity scoring system for Zellweger spectrum disorders (ZSD).
• To establish a reliable tool for objective phenotypic assessment in ZSD patients.

Main Methods:

• Developed a severity score based on 14 typically affected organs in ZSD.
• Utilized the Capacity Profile (CAP) to assess additional care needs.
• Scored 30 ZSD patients of varying ages using the developed severity score and CAP.

Main Results:

• The ZSD severity score showed significant correlation with all 5 domains of the CAP, particularly the sensory domain (r=0.8971, P<.0001).
• No correlation was found between age and severity score, indicating its applicability across all age groups.
• Multiple peroxisomal biochemical parameters significantly correlated with the severity score.

Conclusions:

• The developed ZSD severity score is a suitable tool for assessing phenotypic severity in ZSD patients at any age.
• This score facilitates objective phenotype descriptions, genotype-phenotype correlation studies, and prognostic feature identification.
• The severity score can aid in the classification and stratification of patients for clinical trials.